Cargando…
Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study)
Ototoxicity and nephrotoxicity are potentially irreversible side effects of chemoradiotherapy with cisplatin in locally advanced head and neck cancer (LAHNC) patients. Several predictive genetic variants have been described, but as yet none in LAHNC patients. The aim of this study is to investigate...
Autores principales: | Driessen, Chantal M., Ham, Janneke C., te Loo, Maroeska, van Meerten, Esther, van Lamoen, Maurits, Hakobjan, Marina H., Takes, Robert P., van der Graaf, Winette T., Kaanders, Johannes H., Coenen, Marieke J.H., van Herpen, Carla M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520709/ https://www.ncbi.nlm.nih.gov/pubmed/30999660 http://dx.doi.org/10.3390/cancers11040551 |
Ejemplares similares
-
Genome-Wide Analyses of Nephrotoxicity in Platinum-Treated Cancer Patients Identify Association with Genetic Variant in RBMS3 and Acute Kidney Injury
por: Klumpers, Marije J., et al.
Publicado: (2022) -
Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial
por: Driessen, Chantal M. L., et al.
Publicado: (2017) -
Gentamicin-mediated ototoxicity and nephrotoxicity: A clinical trial study
por: Saleh, Parviz, et al.
Publicado: (2016) -
Methotrexate plus or minus cetuximab as first‐line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib‐randomized phase II study Commence
por: Ham, Janneke C., et al.
Publicado: (2020) -
Mechanisms and pharmacokinetic/pharmacodynamic profiles underlying the low nephrotoxicity and ototoxicity of etimicin
por: Yao, Lan, et al.
Publicado: (2020)